{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:05:33Z","timestamp":1761843933770},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/mcp.0b013e328335dc90","type":"journal-article","created":{"date-parts":[[2010,1,28]],"date-time":"2010-01-28T06:06:35Z","timestamp":1264658795000},"page":"106-111","source":"Crossref","is-referenced-by-count":37,"title":["Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality"],"prefix":"10.1097","volume":"16","author":[{"given":"Joana","family":"Mascarenhas","sequence":"first","affiliation":[]},{"given":"Ana","family":"Azevedo","sequence":"additional","affiliation":[]},{"given":"Paulo","family":"Bettencourt","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R2-5-20210206","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failures 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ECSIM)","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"R3-5-20210206","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijcard.2007.12.001","article-title":"Coexistent chronic obstructive pulmonary disease and heart failure in the elderly","volume":"125","author":"Padeletti","year":"2008","journal-title":"Int J Cardiol"},{"key":"R4-5-20210206","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ejheart.2006.01.010","article-title":"Heart failure and chronic obstructive pulmonary disease: an ignored combination?","volume":"8","author":"Rutten","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"R5-5-20210206","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"R6-5-20210206","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(07)61377-4","article-title":"International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study","volume":"370","author":"Buist","year":"2007","journal-title":"Lancet"},{"key":"R7-5-20210206","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J Med"},{"key":"R8-5-20210206","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"R9-5-20210206","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial.","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"R10-5-20210206","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jacc.2006.08.046","article-title":"Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure","volume":"49","author":"Le Jemtel","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R11-5-20210206","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0954-6111(03)00168-9","article-title":"Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis","volume":"97","author":"Salpeter","year":"2003","journal-title":"Respir Med"},{"key":"R12-5-20210206","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme: a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"R13-5-20210206","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/qjmed\/hci080","article-title":"Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease","volume":"98","author":"Egred","year":"2005","journal-title":"Q J Med"},{"key":"R14-5-20210206","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ejheart.2007.09.008","article-title":"Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey","volume":"9","author":"Groote","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R15-5-20210206","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.amjcard.2007.08.046","article-title":"Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure","volume":"101","author":"Rusinaru","year":"2008","journal-title":"Am J Cardiol"},{"key":"R16-5-20210206","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00508-009-1185-8","article-title":"The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure","volume":"121","author":"Lainscak","year":"2009","journal-title":"Wien Klin Wochenschr"},{"key":"R17-5-20210206","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.ejheart.2007.06.004","article-title":"The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure","volume":"9","author":"Macchia","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R18-5-20210206","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.annepidem.2005.04.008","article-title":"Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients","volume":"16","author":"Curkendall","year":"2006","journal-title":"Ann Epidemiol"},{"key":"R19-5-20210206","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1378\/chest.128.4.2068","article-title":"COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program","volume":"128","author":"Sidney","year":"2005","journal-title":"Chest"},{"key":"R20-5-20210206","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/eurheartj\/ehi291","article-title":"Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease","volume":"26","author":"Rutten","year":"2005","journal-title":"Eur Heart J"},{"key":"R21-5-20210206","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1197\/aemj.10.3.198","article-title":"Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department","volume":"10","author":"McCullough","year":"2003","journal-title":"Acad Emerg Med"},{"key":"R22-5-20210206","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archinte.158.11.1231","article-title":"Managed care and outcomes of hospitalization among elderly patients with congestive heart failure","volume":"158","author":"Ni","year":"1998","journal-title":"Arch Intern Med"},{"key":"R23-5-20210206","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"key":"R24-5-20210206","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1067\/mhj.2002.120773","article-title":"Spectrum of heart failure in older patients: results from National Heart Failure project","volume":"143","author":"Havranek","year":"2002","journal-title":"Am Heart J"},{"key":"R25-5-20210206","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","article-title":"Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure","volume":"42","author":"Braunstein","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R26-5-20210206","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ehj.2003.10.003","article-title":"Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure","volume":"25","author":"Gustafsson","year":"2004","journal-title":"Eur Heart J"},{"key":"R27-5-20210206","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ahj.2007.10.040","article-title":"Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications","volume":"155","author":"Mascarenhas","year":"2008","journal-title":"Am Heart J"},{"key":"R28-5-20210206","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2796.2008.01975.x","article-title":"Chronic obstructive pulmonary disease in patients admitted with heart failure","volume":"264","author":"Iversen","year":"2008","journal-title":"J Intern Med"},{"key":"R29-5-20210206","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1378\/chest.123.5.1684","article-title":"Interpreting COPD prevalence estimates: what is the true burden of disease?","volume":"123","author":"Halbert","year":"2003","journal-title":"Chest"},{"key":"R30-5-20210206","first-page":"1120","article-title":"Discrepancy in the use of confirmatory tests in patients hospitalized with the diagnosis of chronic obstructive pulmonary disease or congestive heart failure","volume":"51","author":"Damarla","year":"2006","journal-title":"Respir Care"},{"key":"R31-5-20210206","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1067\/mhj.2002.126446","article-title":"The relevance of subgroup-specific treatment effects: the studies of left ventricular dysfunction (SOLVD) revisited","volume":"144","author":"Parker","year":"2002","journal-title":"Am Heart J"},{"key":"R32-5-20210206","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cardfail.2007.07.012","article-title":"Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-Heft heart failure trial","volume":"13","author":"Staszewsky","year":"2007","journal-title":"J Card Fail"},{"key":"R33-5-20210206","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1001\/jama.291.16.1963","article-title":"Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial","volume":"291","author":"Gheorghiade","year":"2004","journal-title":"JAMA"},{"key":"R34-5-20210206","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"R35-5-20210206","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000056767.69054.B3","article-title":"Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease","volume":"107","author":"Sin","year":"2003","journal-title":"Circulation"},{"key":"R36-5-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09031936.00128008","article-title":"Systemic manifestations and comorbidities of COPD","volume":"33","author":"Barnes","year":"2009","journal-title":"Eur Respir J"},{"key":"R37-5-20210206","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejheart.2005.01.008","article-title":"Frequent noncardiac comorbidities in patients with chronic heart failure","volume":"7","author":"Dahlstr\u00f6m","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"R38-5-20210206","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejheart.2006.10.017","article-title":"Clinical syndrome suggestive of heart failure is frequently attributable to noncardiac disorders: population-based study","volume":"9","author":"Azevedo","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R39-5-20210206","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/bmj.324.7347.1201","article-title":"ABC of clinical electrocardiography. Conditions affecting the right side of the heart","volume":"324","author":"Harrington","year":"2002","journal-title":"BMJ"},{"key":"R40-5-20210206","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1378\/chest.125.2.669","article-title":"The pulmonary manifestations of left heart failure","volume":"125","author":"Gehlbach","year":"2004","journal-title":"Chest"},{"key":"R41-5-20210206","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/bmj.38664.661181.55","article-title":"Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study","volume":"331","author":"Rutten","year":"2005","journal-title":"BMJ"},{"key":"R42-5-20210206","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1164\/ajrccm.162.2.9908056","article-title":"Left atrial and ventricular filling in chronic obstructive pulmonary disease. An echocardiographic and Doppler study","volume":"162","author":"Boussuges","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R43-5-20210206","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.ehj.2004.06.040","article-title":"Clinical indications of cardiovascular magnetic resonance (CMR): consensus panel report","volume":"25","author":"Pennell","year":"2004","journal-title":"Eur Heart J"},{"key":"R44-5-20210206","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1136\/hrt.2005.063784","article-title":"Clinical usefulness of B-type natriuretic peptide measurement: present and future perspectives","volume":"91","author":"Bettencourt","year":"2005","journal-title":"Heart"},{"key":"R45-5-20210206","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MCC.0b013e3282faa304","article-title":"Detection of acute heart failure in chronic obstructive pulmonary disease patients: role of B-type natriuretic peptide","volume":"14","author":"Abroug","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"R46-5-20210206","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/eurjhf\/hfn005","article-title":"Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology. The Impact-Reco Programme","volume":"11","author":"Groote","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"R47-5-20210206","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1579-2129(09)72937-4","article-title":"Chronic obstructive pulmonary disease and heart failure","volume":"45","author":"Villar Alvarez","year":"2009","journal-title":"Arch Bronconeumol"},{"key":"R48-5-20210206","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.pcrj.2005.06.005","article-title":"Beta-blocker therapy of cardiovascular diseases in patients with bronchial asthma or COPD: the pro viewpoint","volume":"14","author":"Ashrafian","year":"2005","journal-title":"Prim Care Respir J"},{"key":"R49-5-20210206","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1378\/chest.127.3.818","article-title":"Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers","volume":"127","author":"van der Woude","year":"2005","journal-title":"Chest"},{"key":"R50-5-20210206","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jacc.2004.03.063","article-title":"Therapeutic update: nonselective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure","volume":"44","author":"Sirak","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R51-5-20210206","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S1053-2498(02)00459-X","article-title":"Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma","volume":"21","author":"Kotlyar","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"R52-5-20210206","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cardfail.2005.12.001","article-title":"Executive summary: HFSA 2006 comprehensive heart failure practice guideline.","volume":"12","year":"2006","journal-title":"J Card Fail"},{"key":"R53-5-20210206","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/eurjhf\/hfp066","article-title":"Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"R54-5-20210206","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/thorax.58.7.556","article-title":"ACE in COPD: a therapeutic target?","volume":"58","author":"Forth","year":"2003","journal-title":"Thorax"},{"key":"R55-5-20210206","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1183\/09031936.02.00269802","article-title":"A long term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease","volume":"19","author":"Casaburi","year":"2002","journal-title":"Eur Resp J"},{"key":"R56-5-20210206","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1378\/chest.123.6.1964","article-title":"Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction","volume":"123","author":"Au","year":"2003","journal-title":"Chest"},{"key":"R57-5-20210206","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1067\/mhj.2001.118117","article-title":"Left ventricular diastolic dysfunction in patients with bronchial asthma with long-term oral beta2-adrenoreceptor agonists","volume":"142","author":"Hirono","year":"2001","journal-title":"Am Heart J"},{"key":"R58-5-20210206","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1378\/chest.125.6.2309","article-title":"Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis","volume":"125","author":"Salpeter","year":"2004","journal-title":"Chest"},{"key":"R59-5-20210206","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"R60-5-20210206","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1378\/chest.128.4.2005","article-title":"Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001","volume":"128","author":"Holguim","year":"2005","journal-title":"Chest"},{"key":"R61-5-20210206","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1513\/pats.200404-032MS","article-title":"Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality","volume":"2","author":"Sin","year":"2005","journal-title":"Proc Am Thorac Soc"}],"container-title":["Current Opinion in Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCP.0b013e328335dc90","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:33:19Z","timestamp":1620959599000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00063198-201003000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mcp.0b013e328335dc90","relation":{},"ISSN":["1070-5287"],"issn-type":[{"value":"1070-5287","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}